Pathway Genomics has appointed Ardy Arianpour as chief strategy officer. He joins Pathway from Ambry Genetics, where he was most recently senior vice president of development. Previously, he was regional manager of business development at Cogenics. He holds a BS in biological sciences from the University of California, Irvine and an MBA in strategic management from Marshall Goldsmith School of Management.
Baylor College of Medicine's Jim Lupski has received the 2014 Environmental Mutagenesis and Genomics Society Award in recognition of his work in characterizing human mutations and linking them to disease. Lupski, a professor of molecular and human genetics at BCM, has relied on chromosomal microarrays and whole-genome sequencing to discover several disease genes, including the first gene for Charcot-Marie Tooth syndrome.
EMGS recognizes one researcher each year for outstanding research contributions in the area of environmental mutagenesis and genomics. Lupski will receive the award on Sept. 16 at the society's annual meeting in Orlando, Fla.
GenomOncology has named John Doulis to serve on its board of directors, in connection with an investment from TriStar Technology Ventures.
Doulis is chief information officer for MedCare Investment Funds, which is a partner fund to TriStar. He has two decades of experience as a physician, executive, scientist, and healthcare information systems designer and manager, including serving as assistant vice chancellor and chief operations officer for the Informatics Center at Vanderbilt University.